Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality

Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality

Abstract Background Obstructive sleep apnea syndrome (OSA) is currently recognized as an independent risk factor for hypertension, arrhythmia, coronary heart disease, stroke, and metabolic disorders (e.g. diabetes, dyslipidemia). In clinical practice, apnea-hypopnea index (AHI) is the marker used to...

Full description

Bibliographic Details
Main Authors: Stephanie André, Fabio Andreozzi, Chloé Van Overstraeten, Sidali Ben Youssef, Ionela Bold, Sarah Carlier, Alexia Gruwez, Anne-Violette Bruyneel, Marie Bruyneel
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Respiratory Research
Subjects:
Diabetes
Cardiovascular comorbidities
Dyslipidemia
Obstructive sleep apnea
Nocturnal hypoxemia
Sleep quality
Online Access:https://doi.org/10.1186/s12931-020-1284-7

Internet

https://doi.org/10.1186/s12931-020-1284-7

Similar Items